Publications

Tassone B , Saoncella S , Neri F, Ala U , Brusa D , Magnuson MA , Provero P, Oliviero S, Riganti C and Calautti E. Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis. Cell Death and Diff 2017
Bosia C, Sgrò F, Conti L, Baldassi C, Brusa D, Cavallo F, Di Cunto F, Turco E, Pagnani A and Zecchina R. RNAs competing for microRNAs mutually infuence their fluctuations in a highly non-linear microRNA-dependent manner in single cells. Genom Biol 2017
Orso F, Quirico L, Virga F, Penna E, Dettori D, Cimino D, Coppo R, Grassi E, Elia AR, Brusa D, Deaglio S, Brizzi MF, Stadler MB, Provero P, Caselle M, Taverna D. miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer. Cancer Res 2016
Bologna C, Buonincontri R, Serra S, Vaisitti T, Audrito V, Brusa D, Pagnani A, Coscia M, D’Arena G, Mereu E, Piva R, Furman RR, Rossi D, Gaidano G, Terhorst C, Deaglio S. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. JCI 2015
Massi D*, Brusa D*, Merelli B, Ciano M, Audrito V, Serra S, Buonincontri R, Baroni G, Nassini R, Minocci D, Cattaneo L, Tamborini E, Carobbio A, Deaglio S^§, Mandalà M^§. PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. *co-first and ^§co-last authors. Annals of Oncology, 2014
Rolla S, Bardina B, De Mercanti S, Quaglino P, De Palma R, Gned D, Brusa D, Durelli L, Novelli F, Clerico M. Th22 cells are expanded in multiple sclerosis and are resistant to IFNβ. Journal of Leukocyte Biology 2014
Brusa D, Simone M, Gontero P, Spadi R, Racca P, Micari J, Degiuli M, Carletto S, Tizzani A, Matera L. Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison. Int J Urol. 2013